Current and future utilization of services from medical oncologists.

PURPOSE There is limited information on the current use of oncologists and projections of future need. This analysis assesses current utilization patterns and projects the number of people with cancer and their use of oncologists' services through 2020. METHODS Data from the Surveillance, Epidemiology, and End Results cancer registries and Medicare physician claims were used to estimate oncologists' services from 1998 to 2003. We estimated the portion of patients with cancer who saw an oncologist, the mean number of visits, and the clinical setting where care was provided. Care was divided into initial, continuing, and last-year-of-life phases. Projections for future number of patients with cancer and visits were calculated by applying incidence and prevalence rates derived from Surveillance, Epidemiology, and End Results data to census population projections through 2020. RESULTS The percentage of patients who saw an oncologist was 47% during the initial-care phase, 36% during the continuing-care phase, and 70% in the last year of life. The number of visits varied by age, sex, cancer site, and phase. The total number of cancer patients in the United States is projected to increase 55%, from 11.8 million in 2005 to 18.2 million in 2020. Total oncology visits are projected to increase from 38 million in 2005 to 57 million in 2020. CONCLUSION Utilization of oncologists' services will increase appreciably between 2005 and 2020; this will be driven predominantly by an increase in survivors of cancer and by the aging of the population. The United States may face an acute shortage of medical oncologists if efforts are not taken to meet this growing need.

[1]  Michael Halpern,et al.  Association of Insurance with Cancer Care Utilization and Outcomes , 2008, CA: a cancer journal for clinicians.

[2]  Suanna S Bruinooge,et al.  Future supply and demand for oncologists : challenges to assuring access to oncology services. , 2007, Journal of oncology practice.

[3]  E. Feuer,et al.  Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000–2020 , 2006, Cancer Causes & Control.

[4]  L. Clegg,et al.  Patterns of Care for Adjuvant Therapy in a Random Population-Based Sample of Patients Diagnosed with Colorectal Cancer , 2006, The American Journal of Gastroenterology.

[5]  E. Elkin,et al.  Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Goodwin,et al.  Use and outcomes of adjuvant chemotherapy in older women with breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  L. Clegg,et al.  Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  C. Earle,et al.  Under use of necessary care among cancer survivors , 2004, Cancer.

[9]  K. Langa,et al.  Out-of-pocket health-care expenditures among older Americans with cancer. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  C. Klabunde,et al.  Linking Physician Characteristics and Medicare Claims Data: Issues in Data Availability, Quality, and Measurement , 2002, Medical care.

[11]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[12]  C. Begg,et al.  Age and adjuvant chemotherapy use after surgery for stage III colon cancer. , 2001, Journal of the National Cancer Institute.

[13]  M. Schapira,et al.  Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. , 1997, Journal of clinical epidemiology.

[14]  Dan Gherkin,et al.  An Evaluation of the American Medical Association's Physician Masterfile as a Data Source‐ One State's Experience , 1977, Medical care.